Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Amar U Kishan, et al. on X:
“HYDRA Study (MARCAP):
Moderately hypofractionated radiotherapy (MHFRT) is as effective as conventionally fractionated radiotherapy (CFRT).
Dose-escalated MHFRT increases bowel toxicity without survival benefit.”
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium
Author: Amar U Kishan,et al.
More posts featuring Yüksel Ürün.